CompaniesPharmasset

Pharmasset

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (13)
View all

Total Trials

13

As Lead Sponsor

8

As Collaborator

5

Total Enrollment

2,298

By Phase

PHASE2: 3PHASE3: 4NA: 1PHASE1/PHASE2: 1PHASE1: 2

By Status

COMPLETED: 5UNKNOWN: 3TERMINATED: 3RECRUITING: 2
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT00496002
NCT00496158
Hover over trial bars to see details

Recent Trials

NCT06879327Collaborator
Infant Malaria Vaccine Schedule Optimization
PHASE2Recruiting
1,200 participants
Started: May 30, 2025 · Completed: Mar 22, 2028
NCT05549752Collaborator
Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
PHASE3Recruiting
80 participants
Started: Mar 24, 2023 · Completed: Jan 30, 2026
NCT04480814Lead Sponsor
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
N/AUnknown
120 participants
Started: Oct 11, 2019 · Completed: Jun 11, 2023
NCT04490564Lead Sponsor
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
N/AUnknown
185 participants
Started: Jun 25, 2019 · Completed: Jun 25, 2023
NCT04821388Collaborator
Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries
NAUnknown
30 participants
Started: Jan 11, 2019 · Completed: Aug 30, 2021
View all 13 trials →
Funding History (20)
8-K
Jan 17, 2012
Filing
8-K
Jan 13, 2012
Filing
8-K
Jan 12, 2012
Filing
8-K
Dec 22, 2011
Filing
8-K
Dec 16, 2011
Filing
8-K
Nov 21, 2011
Filing
8-K
Nov 4, 2011
Filing
8-K
Sep 30, 2011
Filing
8-K
Sep 14, 2011
Filing
8-K
Sep 7, 2011
Filing